doctor stetoscope
Our Work

Latham & Watkins Advises on Outset Medical’s US$300 Million Debt Facilities

November 4, 2022
Firm advises on another leading structured medical device debt facility. 

Outset Medical, Inc. (Nasdaq: OM), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, has announced that it has entered into two senior secured credit facilities with investment affiliates managed by SLR Capital Partners, LLC which collectively provide for borrowings of up to US$300 million, comprising up to a US$250 million term loan facility and up to a US$50 million asset-based revolving credit facility.

Latham & Watkins LLP represented SLR Capital Partners, LLC in the transaction with a team led by Bay Area partners Haim Zaltzman and Dan Van Fleet, with Los Angeles associate Hai Pham and Houston associate Michelle Synhorst. Advice was also provided on tax matters by Los Angeles partner Eric Cho; on FDA regulatory matters by Washington D.C. partner Ben Haas, Bay Area counsel Betty Pang and Washington D.C. associate Chad Jennings; and on convertible debt matters by New York partner Reza Mojitabaee-Zamani, with associates Eric Rice and Qinwen (Kevin) Zhang.